🏛️ Verified NIH Record • Updated 2026-07-02

GYNEMESH PS Mesh Post Marketing Clinical Follow-Up Study (NCT04829058)

A Retrospective and Long-Term Prospective Post Market Clinical Follow-up (PMCF) Study of the GYNECARE GYNEMESH® PS Nonabsorbable PROLENE® Soft Mesh

🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: Ethicon, Inc.

🩺 Plain-English Summary (8th-Grade Level)

The objective of this retrospective and prospective, single-arm, observational, multicenter, post-market study is to evaluate outcomes in women who underwent surgery for vaginal or uterine prolapse with a GYNEMESH PS Mesh.

Who can join: Review the eligibility criteria below.

Location: Institute for Female Pelvic Medicine — North Wales, Pennsylvania

Age range: 21 Years

🧪 Interventions in This Study

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (3 Sites)

  • Institute for Female Pelvic Medicine — North Wales, Pennsylvania
  • UMPC — Pittsburgh, Pennsylvania
  • Universitatsklinikum Tubingen — Tübingen,

📞 Contact the Study Coordinator

Phone: (908) 808-6219

Email: cromanow@its.jnj.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

💡 How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
🏛️ View Official NIH Record ↗